ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, E.
Right arrow Articles by Idell, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, E.
Right arrow Articles by Idell, S
Eur Respir J 1999; 14: 1387-1393
Copyright © ERS Journals Ltd 1999


Original Articles

Chemokine involvement in tetracycline-induced pleuritis

EJ Miller, O Kajikawa, S Pueblitz, RW Light, KK Koenig, and S Idell

Sclerosants such as tetracycline (TCN) have often been used in the control of malignant pleural effusions. Although the resultant inflammatory response is probably important in the ensuing pleural fibrosis, the signals responsible for the cellular influx into the pleural space following TCN instillation are not well understood. This study, therefore, sought to determine whether the chemokines interleukin-8 (IL-8), growth-related protein (Gro), and monocyte chemotactic protein-1 (MCP-1) were locally elaborated within the first 72 h following intrapleural TCN administration. TCN induced an exudative effusion with high lactate dehydrogenase activity. Although there was no significant change in the pleural fluid total leukocyte content, the median polymorphonuclear neutrophil concentration decreased from 1.067x10(6) to 2.03x10(5) cells x mL(-1) between 24 and 72 h, whereas the median macrophage concentration increased from 1.44x10(5) to 5.98x10(5) cells x mL(-1) over the same period. Furthermore, IL-8, Gro and MCP-1 concentrations decreased between 24 and 72 h. Immunocytochemistry indicated expression of IL-8 by pleural mesothelial cells 24 h, but not 72 h, following TCN administration. The data suggest that local elaboration of interleukin-8 and growth-related protein, in part of mesothelial origin, may influence neutrophil recruitment in tetracycline-induced pleuritis.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Idell, T. Allen, S. Chen, K. Koenig, A. Mazar, and A. Azghani
Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L25 - L32.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. B. Guo, I. Kalomenidis, M. Hawthorne, K. S. Parman, K. B. Lane, and R. W. Light
Pleurodesis Is Inhibited by Anti-Vascular Endothelial Growth Factor Antibody
Chest, September 1, 2005; 128(3): 1790 - 1797.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Y.C.G. Lee, K.B. Lane, O. Zoia, P.J. Thompson, R.W. Light, and T.S. Blackwell
Transforming growth factor-{beta} induces collagen synthesis without inducing IL-8 production in mesothelial cells
Eur. Respir. J., August 1, 2003; 22(2): 197 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. N. Georas, L. A. Beck, and C. Stellato
What Is Eotaxin Doing in the Pleura? . Insights into Innate Immunity from Pleural Mesothelial Cells
Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 384 - 387.
[Full Text] [PDF]


Home page
ChestHome page
N. Hata, K. Tanaka, T. Imaizumi, T. Ohara, T. Ohba, T. Shinada, and T. Takano
Clinical Significance of Pleural Effusion in Acute Aortic Dissection
Chest, March 1, 2002; 121(3): 825 - 830.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.